Across its client base, Virta has: Discontinued GLP-1 use in over 50% of active users Kept GLP-1 utilization under 25% across all weight loss members Achieved about 5% average weight loss in 90 days, with durable outcomes post-medication Optional outcomes-based contracts available for employers seeking risk alignment Omada Health supports chronic disease and weight management through connected devices, digital coaching, and virtual care teams
Which one you should choose will depend on your individual skin concerns
Imaging glial activation in patients with post-treatment Lyme disease symptoms: a pilot study using [11C]DPA-713 PET
Completely different outcomes
Expert Review of Gastroenterology & Hepatology, 11 (9), 821
Neuroinflammation As neuroinflammation has been suggested to be responsible for other fatigue-related neurologic diseases, such as multiple sclerosis [118], neuroinflammation has also been hypothesized to contribute to ME/CFS